(Q44277489)

1 December 2017

title

Methotrexate therapy for primary biliary cirrhosis (English)

1 reference

primary biliary cholangitis

1 December 2017

main subject

0 references

1 reference

2

Carol Bodian

1 reference

1 December 2017

Nancy Bach

1

1 reference

1 December 2017

Henry Bodenheimer

3

1 reference

1 December 2017

Edward Croen

4

1 reference

1 December 2017

Paul D Berk

5

1 reference

1 December 2017

Swan N Thung

6

1 reference

1 December 2017

Keith D Lindor

7

1 reference

1 December 2017

Thierry Therneau

8

1 reference

1 December 2017

Fenton Schaffner

9

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

The American Journal of Gastroenterology

1 December 2017

published in

1 reference

1 December 2017

volume

98

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

187-193

1 reference

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07173.X

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07173.X

Primary biliary cirrhosis: how should we evaluate new treatments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07173.X

The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07173.X

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07173.X

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07173.X

10.1111/J.1572-0241.2003.07173.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference